Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49 | 62 | 75 | 79 | 85 |
| TOTAL | $54 | $63 | $75 | $80 | $86 |
| Non-Current Assets | |||||
| PPE Net | 6 | 1 | 1 | 1 | 1 |
| Investments And Advances | 61 | 61 | 61 | 61 | 61 |
| TOTAL | $67 | $62 | $62 | $62 | $62 |
| Total Assets | $121 | $125 | $137 | $142 | $148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50 | 46 | 42 | 38 | 36 |
| TOTAL | $50 | $46 | $42 | $38 | $36 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | -2 | -1 | -1 | -1 |
| TOTAL | $N/A | $-2 | $N/A | $-1 | $-1 |
| Total Liabilities | $50 | $45 | $42 | $37 | $35 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 314 | 314 | 314 | 314 | 314 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -139 | -132 | -115 | -106 | -97 |
| Other shareholders' equity | -2 | 0 | -1 | 0 | 0 |
| TOTAL | $71 | $80 | $95 | $105 | $113 |
| Total Liabilities And Equity | $121 | $125 | $137 | $142 | $148 |